Neoplasia/BPH

	Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma. Discov Oncol Zhou Y, Hu Z, Xie L, Zhang S, Huang Q, Zhang N, Liu Y, Zhang W, Wang K. PMID: 42250062 [PubMed - as supplied by publisher]
	Microstructure imaging of prostate cancer by diffusion MRI. MAGMA Szczepankiewicz F, Panagiotaki E, Molendowska M, Sandeman K, Palombo M, Wu D. PMID: 42250048 [PubMed - as supplied by publisher]
	Impact of CKD on perioperative outcomes following TURBT: a national NSQIP analysis. World J Urol Touma Sawaya R, Nasrallah O, El Hajj A, Abdessater M. PMID: 42249173 [PubMed - indexed for MEDLINE]
	Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learning. NPJ Digit Med Lee JH, Li CX, Jahanandish H, Bhattacharya I, Vesal S, Song Y, Zhang L, Sang S, Choi MH, Soerensen SJC, Zhou SR, Sommer ER, Seibert TM, Fan R, Ghanouni P, Sonn GA, Rusu M. PMID: 42249085 [PubMed - as supplied by publisher]
	Epigenetic modulation of prostate cancer disparities in men with African ancestry. Nat Rev Urol Craddock J, Hayes VM. PMID: 42249067 [PubMed - as supplied by publisher]
	Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study. Eur J Surg Oncol Filzmayer M, Quarta L, Petix M, Orlandi F, Goyal JA, Briganti A, Carmignani L, Micali S, Shariat SF, Kosiba M, Humke C, Saad F, Chun FK, Karakiewicz PI. PMID: 42247963 [PubMed - as supplied by publisher]
	Artificial intelligence in prostate cancer imaging: A mini-review of current applications and future directions. Urol Oncol Ergül MA, Sabur V. PMID: 42247882 [PubMed - as supplied by publisher]
	Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer. Urol Oncol Yajima S, Yoshida S, Chen W, Fukushima H, Tanaka H, Sato H, Hirakawa A, Masuda H, Fujii Y. PMID: 42247881 [PubMed - as supplied by publisher]
	Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan. Jpn J Clin Oncol Sugahara D, Murofushi KN, Yamashita H, Ogo E, Kikuchi K, Saito AI, Komiyama T, Imano N, Igarashi A, Ohno S, Onishi H. PMID: 42247594 [PubMed - as supplied by publisher]
	Integrative Biology Approaches Uncover Plasticizers' Pro-Carcinogenic Role in Prostate Cancer via Molecular Docking and Network Toxicology. OMICS Huang J, Huang Y, Huang Y, Lin Z, Liao L, Yang L, Chen S. PMID: 42247313 [PubMed - as supplied by publisher]
	Precise zonal diagnosis: multi-b-value DWI model reveals differential predictors of clinically significant prostate cancer in peripheral and transition zones. Insights Imaging He K, Chen Y, Kang Z, Li S, Gao M, Yin T, Chen W, Darwish O, Li Z. PMID: 42247047 [PubMed]
	Costing the national clinical guidelines for prostate cancer control and management in South Africa: Public sector perspective. S Afr Med J Thsehla E, Khoza M, Boachie MK, Mdewa W, Goldstein S, Somaroo H, Hofman KJ. PMID: 42246791 [PubMed - indexed for MEDLINE]
	Toward the genetic landscape of prostate cancer in India: insights from whole-exome and low-pass whole-genome sequencing of formalin-fixed paraffin-embedded tumor tissues. Front Syst Biol Biswas S, Rajarathinam B, Khilwani B, Jalendra G, Sharma D, Vijavargiya M, Aradhya R, Ansari AS, Shukla N, Chaubey G, Lohiya NK, Suravajhala P, CA Prostate Consortium of India (CAPCI). PMID: 42246034 [PubMed]
	Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk. Res Sq Fuller H, Rohde R, Highland HM, Haessler J, Wu L, Graff M, Platz EA, Alkis T, Yu B, Boerwinkle E, Grove M, Kooperberg C, Peters U, North KE, Conti DV, Haiman CA, Young KL, Graff RE, Darst BF. PMID: 42245788 [PubMed]
	Detection of microplastics in bladder wash fluid obtained after cystoscopy in patients diagnosed with bladder cancer. Front Public Health Y, Ataman M, Tuna A. PMID: 42245347 [PubMed - indexed for MEDLINE]
	Validation, implementation, and impact of an AI model in routine practice for pathologic diagnosis of prostate cancer in an academic medical center. J Pathol Inform Udoh AI, Eyzaguirre E, Muthukumarana V, Thaker HM. PMID: 42245328 [PubMed]
	Therapeutic pressure drives the evolution of a protective ecotype characterized by AR-loss-induced senescence in prostate cancer. Theranostics He L, Jiang J, Liu S, Song H, Lu T, Hu Z, Li Y, Zhu H, Zhou Y, Li Z, Yang F, Zhang K, Zhang R, Wu T, Gan K, Zhao B, Zhang J, Si D, Zhang R, Shi C, Wen W, Han D, Xu C, Qin W. PMID: 42244988 [PubMed - in process]
	Comparative outcomes of focal HIFU versus active surveillance in low- and intermediate-risk localized prostate cancer: a 75-month retrospective cohort study. Front Urol Jaabou M, Buscarini M, Zaytoun O, Dovey Z, Hildebrand B, Awan M, Bada M, Al Ogaili M, Rabie A. PMID: 42244908 [PubMed]
	The Research Progress of Tumor-Associated Macrophages in Prostate Cancer. J Immunol Res Shen S, Tang Z, Guo C, Chen A, Mi Y. PMID: 42244152 [PubMed - in process]
	Integrative Transcriptomic Signature of tRNA-Derived Fragment Targets and Lactylation-Related Genes for Prostate Cancer Diagnosis. Cancer Med Wang L, Hu X, Wang B, Zhang Y, Yang J, Wang Y. PMID: 42244032 [PubMed - in process]

Articles 1 - 20 / 188377

Page 1 of 9419



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy